Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma.

Abstract

VeIP has significant curative potential in patients with recurrent seminoma and appears to produce a higher CR rate and more long-term survivors than is achieved in patients with nonseminomatous disease.